370. Efficacy of Cochleated Amphotericin B (C-AMB) in Mouse Models of Oropharyngeal and Vulvovaginal Candidiasis

類似資料

• 149. Efficacy of Cochleated Amphotericin B (CAMB) in Mouse and Human Mucocutaneous Candidiasis
  著者:: Desai, Jigar V, 等
  出版事項: (2020)
• 1413. A Phase IIa Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of Encochleated Amphotericin B in Patients with Mucocutaneous (Esophogeal, Oropharyngeal, Vulvovaginal) Candidiasis Who are Refractory or Intolerant to Standard Non-Intravenous Therapies
  著者:: Kibathi, Lilian, 等
  出版事項: (2018)
• Efficacy of Oral Cochleate-Amphotericin B in a Mouse Model of Systemic Candidiasis
  著者:: Santangelo, Rosaria, 等
  出版事項: (2000)
• Pharmacokinetic-Pharmacodynamic Comparison of Amphotericin B (AMB) and Two Lipid-Associated AMB Preparations, Liposomal AMB and AMB Lipid Complex, in Murine Candidiasis Models
  著者:: Andes, D., 等
  出版事項: (2006)
• Vulvovaginal candidiasis
  著者:: Marrazzo, Jeanne
  出版事項: (2002)